. 2016 Sep 26;6:33720. doi: 10.1038/srep33720

Table 3. The IC₅₀ values of all isolated compounds on H1299 and Bel-7402, respectively.

Compound	H1299 IC₅₀ (μM)	Bel IC₅₀ (μM)	Compound	H1299 IC₅₀ (μM)	Bel IC₅₀ (μM)
1	4.42 ± 0.21	11.33 ± 0.39	11	6.25 ± 0.47	15.82 ± 1.32
2	7.05 ± 0.26	NE	12	7.61 ± 0.37	27.02 ± 1.84
3	24.3 ± 0.34	NE	13	8.87 ± 0.47	29.20 ± 2.56
4	NE	NE	14	11.2 ± 0.62	22.93 ± 0.91
5	13.42 ± 1.24	32.31 ± 1.83	15	28.06 ± 1.52	NE
6	5.11 ± 0.36	21.45 ± 2.10	16	8.29 ± 1.01	23.27 ± 0.56
7	1.13 ± 0.21	19.81 ± 1.56	17	2.35 ± 0.15	19.97 ± 0.45
8	6.52 ± 0.27	19.81 ± 0.82	18	8.21 ± 0.24	34.07 ± 0.95
9	14.96 ± 0.68	22.11 ± 0.62	DOX	10.26 ± 0.37	≥ 40
10	15.93 ± 0.83	19.46 ± 1.27

All experiments were repeated three times. NE indicated no effect and doxorubicin (DOX) was used as positive control.

Table 3. The IC50 values of all isolated compounds on H1299 and Bel-7402, respectively.